DOI=10.1007/BF01753729
Jacubovich R., Dore J.-F.
Tumour-associated antigens in culture medium of malignant melanoma cell strains.
Cancer Immunol. Immunother. 7:59-64(1979)

PubMed=3882112; DOI=10.1038/bjc.1985.45; PMCID=PMC1976943
Jacubovich R., Cabrillat H., Gerlier D., Bailly M., Dore J.-F.
Tumourigenic phenotypes of human melanoma cell lines in nude mice determined by an active antitumour mechanism.
Br. J. Cancer 51:335-345(1985)

DOI=10.1159/000417158
Bertrand S., Bailly M., Nguyen M.-J., Dore J.-F.
Cytogenetic characterization of human melanoma metastatic variants: role of chromosome 7?
(In book chapter) Immune-deficient animals in experimental medicine; Wu B.-Q., Zheng J. (eds.); pp.135-139; Karger; Basel; Switzerland (1989)

DOI=10.1159/000417159
Bailly M., Bertrand S., Dore J.-F.
Experimental model of human tumor spontaneous metastasis in immunosupressed newborn rat.
(In book chapter) Immune-deficient animals in experimental medicine; Wu B.-Q., Zheng J. (eds.); pp.140-146; Karger; Basel; Switzerland (1989)

PubMed=1937961; DOI=10.1002/ijc.2910490520
Bailly M., Dore J.-F.
Human tumor spontaneous metastasis in immunosuppressed newborn rats II. Multiple selections of human melanoma metastatic clones and variants.
Int. J. Cancer 49:750-757(1991)

PubMed=1503405
Bailly M., Dore J.-F.
Clonal drift and role of chromosome dosage in human melanoma metastatic cell lines: a statistical analysis.
Anticancer Res. 12:1163-1172(1992)

PubMed=8471837; DOI=10.1097/00008390-199304000-00008
Bailly M., Bertrand S., Dore J.-F.
Increased spontaneous mutation rates and prevalence of karyotype abnormalities in highly metastatic human melanoma cell lines.
Melanoma Res. 3:51-61(1993)

PubMed=8012932; DOI=10.1016/0304-3835(94)90197-x
Mey A., Berthier-Vergnes O., Apoil P.A., Dore J.-F., Revillard J.-P.
Expression of the galactose binding protein Mac-2 by human melanoma cell-lines.
Cancer Lett. 81:155-163(1994)

PubMed=8125107; DOI=10.1111/j.1432-1033.1994.tb18647.x
Boukerche H., Benchaibi M., Berthier-Vergnes O., Lizard G., Bailly M., Bailly M., McGregor J.L.
Two human melanoma cell-line variants with enhanced in vivo tumor growth and metastatic capacity do not express the beta 3 integrin subunit.
Eur. J. Biochem. 220:485-491(1994)

PubMed=8175891; DOI=10.1002/jcb.240540205
Zebda N., Bailly M., Brown S., Dore J.-F., Berthier-Vergnes O.
Expression of PNA-binding sites on specific glycoproteins by human melanoma cells is associated with a high metastatic potential.
J. Cell. Biochem. 54:161-173(1994)

PubMed=7874696; DOI=10.1016/0304-3835(94)03624-r
Thomas C.P., Buronfosse A., Portoukalian J., Fertil B.
Correlation between the radiosensitivity in vitro of clones and variants derived from a human melanoma cell line and their spontaneous metastatic potential in vivo.
Cancer Lett. 88:221-225(1995)

PubMed=9043018; DOI=10.1038/bjc.1997.115; PMCID=PMC2063334
Thomas C.P., Buronfosse A., Portoukalian J., Fertil B.
The gangliosides as a possible molecular coupling factor between the proportion of radiosensitive cells in vitro and the metastatic potential in vivo within a human melanoma cell line.
Br. J. Cancer 75:639-649(1997)

PubMed=17970093
Bertucci F., Pages C., Finetti P., Rochaix P., Lamant L., Devilard E., Nguyen C., Houlgatte R., Birnbaum D., Xerri L., Brousset P.
Gene expression profiling of human melanoma cell lines with distinct metastatic potential identifies new progression markers.
Anticancer Res. 27:3441-3449(2007)